Tag Archives: migraine

Study: Cannabis May Cut Headache And Migraine Pain In Half – CBS Sacramento

PULLMAN, Wash. (CBS Local) — Cannabis could be used to relieve headache pain, a new study from Washington State University suggests. Inhaled cannabis reduced self-reported headache severity by 47.3 percent and migraine severity by 49.6 percent, according to new research. The study, conducted by Washington State University and published online in the Journal of Pain,… Read More »

Lilly scores FDA nod for new migraine drug Reyvow

Eli Lilly is already working to grow market share for its migraine prevention med Emgality, but now the company has a new medicine to add to its suite.  The drugmaker Friday won approval for Reyvow for the acute treatment of migraines as they occur. The drug, formerly known as lasmiditan, becomes the latest launch in Lilly’s pain and migraine franchise, which it bolstered… Read More »

Novel Therapy for Acute Migraine Shows Promise in Phase 3 Clinical Trial

(BRONX, NY)—A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in the July 11 issue of The New England Journal of Medicine. The drug, rimegepant, is awaiting U.S. Food and Drug Administration approval and may… Read More »

Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters. FILE PHOTO: The logo of Lilly is seen… Read More »